3.0.0 4065 2022-12-31T04:59:30Z 2022-12-31T04:59:30Z House HR 2021-06-22 117 [Congressional Record Volume 167, Number 108 (Tuesday, June 22, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SEWELL:H.R. 4065.Congress has the power to enact this legislation pursuantto the following:Article l, Section 8 of the U.S. Constitution.[Page H3007]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2021-06-23T22:13:22Z Referred to 2021-06-22T16:02:25Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2021-06-22T20:27:26Z Referred to 2021-06-22T16:02:30Z Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 117 1971 S 2021-06-08 Read twice and referred to the Committee on Finance. Related bill CRS Jack Reynolds Memory Medigap Expansion Act 117 1676 HR 2021-03-10 Referred to the Subcommittee on Health. Related bill CRS 2021-06-23 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2021-06-22 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2021-06-22 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2021-06-22 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2021-06-22 Introduced in House IntroReferral Intro-H 9 Library of Congress 2021-06-22 Introduced in House IntroReferral 1000 9 Library of Congress S001185 Rep. Sewell, Terri A. [D-AL-7] Terri Sewell D AL A. 7 N B001260 Rep. Buchanan, Vern [R-FL-16] Vern Buchanan R FL 16 2021-06-22 True J000126 Rep. Johnson, Eddie Bernice [D-TX-30] EDDIE JOHNSON D TX BERNICE 30 2021-07-16 False P000610 Del. Plaskett, Stacey E. [D-VI-At Large] Stacey Plaskett D VI E. 0 2021-07-16 False F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2021-07-16 False P000604 Rep. Payne, Donald M., Jr. [D-NJ-10] Donald Payne D NJ M. 10 2021-09-10 False C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2021-09-28 False O000171 Rep. O'Halleran, Tom [D-AZ-1] Tom O'Halleran D AZ 1 2021-11-18 False K000382 Rep. Kuster, Ann M. [D-NH-2] Ann Kuster D NH M. 2 2022-01-19 False T000481 Rep. Tlaib, Rashida [D-MI-13] Rashida Tlaib D MI 13 2022-05-12 False Health Administrative law and regulatory procedures Congressional oversight Department of Health and Human Services Digestive and metabolic diseases Drug therapy Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health facilities and institutions Health promotion and preventive care Health technology, devices, supplies Medicaid Medical research Medical tests and diagnostic methods Medicare Minority health Organ and tissue donation and transplantation State and local government operations Health 00 2021-06-22 Introduced in House 2021-12-30T21:31:22Z Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease.

Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease (ESRD) to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.

The bill also extends the coordination period (from 30 months to 42 months) during which private health insurers may serve as the primary payers for Medicare beneficiaries with ESRD.

]]> Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 Official Title as Introduced To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes. Introduced in House IH Display Title Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 Short Title(s) as Introduced Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 Introduced in House IH Introduced in House 2021-06-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117hr4065ih/xml/BILLS-117hr4065ih.xml 2021-06-23 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.